• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过家庭血压测量确定四种选择性血管紧张素II 1型受体阻滞剂(氯沙坦、坎地沙坦、缬沙坦和替米沙坦)对原发性高血压患者的疗效及作用持续时间。

Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.

作者信息

Nishimura Takuya, Hashimoto Junichiro, Ohkubo Takayoshi, Kikuya Masahiro, Metoki Hirohito, Asayama Kei, Totsune Kazuhito, Imai Yutaka

机构信息

Department of Clinical Pharmacology and Therapeutics, Tohoku University School of Pharmaceutical Science and Medicine, Sendai, Japan.

出版信息

Clin Exp Hypertens. 2005 Aug;27(6):477-89. doi: 10.1081/CEH-200067668.

DOI:10.1081/CEH-200067668
PMID:16081340
Abstract

Our objective was to compare the efficacy and duration of action of 4 angiotensin II receptor blockers (ARBs)--losartan (25-100 mg), candesartan (2-12 mg), valsartan (40-80 mg), and telmisartan (10-40 mg)-in patients with essential hypertension using self-measurement of blood pressure at home (home BP) and to examine the differential effect of the four ARBs on home pulse pressure (home PP). After a 2-week run-in period, each of the 4 ARBs was assigned to subjects who were diagnosed as having hypertension on the basis of home BP and who were over 30 years old. The subjects were asked to take the ARB once daily in the morning and to measure home BP once in the evening and in the morning. We compared the efficacy of each ARB on home BP and home PP and assessed the duration of the BP-lowering effect using the morning effect versus evening effect ratio (M/E ratio). The antihypertensive effects of telmisartan on home systolic BP (SBP) both in the evening and in the morning and on home diastolic BP (DBP) in the morning were significantly greater than those of losartan. The effect of each ARB on home BP in the morning and in the evening was expressed as a ratio (M/E ratio). The M/E ratios of SBP/DBP in patients treated with losartan, candesartan, valsartan, and telmisartan were 0.49/0.16, 0.69/1.01, 0.82/0.88, and 0.88/0.88, respectively. The home PP-lowering effect was greater for valsartan and telmisartan than for losartan and candesartan in the morning. Among the 4 ARBs, the duration of the BP-lowering effect of losartan did not persist throughout 24 hr. The effects of the other 3 ARBs, in particular telmisartan, persisted over 24 hr when they were administered once daily in the morning. In addition, the duration of the PP-lowering effect was similar to that of the BP-lowering effect. Such long-acting property of several ARBs is essential for the modern antihypertensive treatment, and home BP measurements are useful for determining the duration of action of antihypertensive drugs. Losartan, 25 mg a day, which is usually used as an initial dose in Japan, is apparently insufficient to obtain adequate antihypertensive effect and sufficient duration of action.

摘要

我们的目标是,通过家庭自测血压(家庭血压),比较4种血管紧张素II受体阻滞剂(ARB)——氯沙坦(25 - 100毫克)、坎地沙坦(2 - 12毫克)、缬沙坦(40 - 80毫克)和替米沙坦(10 - 40毫克)——对原发性高血压患者的疗效和作用持续时间,并研究这4种ARB对家庭脉压(家庭PP)的不同影响。在为期2周的导入期后,将4种ARB分别分配给根据家庭血压被诊断为患有高血压且年龄超过30岁的受试者。受试者被要求每天早晨服用一次ARB,并在晚上和早晨各测量一次家庭血压。我们比较了每种ARB对家庭血压和家庭PP的疗效,并使用早晨效应与晚上效应比(M/E比)评估降压作用的持续时间。替米沙坦对晚上和早晨的家庭收缩压(SBP)以及早晨的家庭舒张压(DBP)的降压作用均显著大于氯沙坦。每种ARB对早晨和晚上家庭血压的作用以比值(M/E比)表示。接受氯沙坦、坎地沙坦、缬沙坦和替米沙坦治疗的患者,其SBP/DBP的M/E比分别为0.49/0.16、0.69/1.01、0.82/0.88和0.88/0.88。早晨,缬沙坦和替米沙坦对家庭PP的降低作用大于氯沙坦和坎地沙坦。在这4种ARB中,氯沙坦的降压作用持续时间在24小时内并不持久。当其他3种ARB每天早晨服用一次时,其作用持续超过24小时,尤其是替米沙坦。此外,PP降低作用的持续时间与降压作用的持续时间相似。几种ARB的这种长效特性对现代降压治疗至关重要,家庭血压测量有助于确定降压药物的作用持续时间。在日本通常用作初始剂量的每天25毫克氯沙坦,显然不足以获得足够的降压效果和充分的作用持续时间。

相似文献

1
Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.通过家庭血压测量确定四种选择性血管紧张素II 1型受体阻滞剂(氯沙坦、坎地沙坦、缬沙坦和替米沙坦)对原发性高血压患者的疗效及作用持续时间。
Clin Exp Hypertens. 2005 Aug;27(6):477-89. doi: 10.1081/CEH-200067668.
2
Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy.比较替米沙坦和缬沙坦作为氨氯地平单药治疗晨峰血压控制不佳的高血压患者的附加治疗药物的效果。
Hypertens Res. 2014 Mar;37(3):225-31. doi: 10.1038/hr.2013.141. Epub 2013 Oct 10.
3
Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.血管紧张素II受体阻滞剂替米沙坦与缬沙坦对血压昼夜变化的影响:对清晨时段的影响。
Am J Hypertens. 2004 Apr;17(4):347-53. doi: 10.1016/j.amjhyper.2004.02.016.
4
A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.一项前瞻性、随机、开放标签试验,采用动态血压监测比较替米沙坦80毫克与缬沙坦80毫克治疗轻度至中度高血压患者的疗效。
Can J Cardiol. 2000 Sep;16(9):1123-32.
5
Effect of switching from telmisartan, valsartan, olmesartan, or losartan to candesartan on morning hypertension.从替米沙坦、缬沙坦、奥美沙坦或氯沙坦切换为坎地沙坦对晨峰高血压的影响。
Clin Exp Hypertens. 2012;34(2):86-91. doi: 10.3109/10641963.2011.628729. Epub 2012 Jan 17.
6
Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.替米沙坦/氢氯噻嗪40/12.5毫克和80/12.5毫克固定剂量组合与氯沙坦/氢氯噻嗪50/12.5毫克固定剂量组合治疗轻度至中度原发性高血压的比较:两项多中心、前瞻性、随机、开放标签、盲终点(PROBE)试验的汇总分析
Clin Ther. 2005 Nov;27(11):1795-805. doi: 10.1016/j.clinthera.2005.11.014.
7
Comparative effect of candesartan and amlodipine, and effect of switching from valsartan, losartan, telmisartan and olmesartan to candesartan, on early morning hypertension and heart rate.坎地沙坦与氨氯地平的比较效果,以及从缬沙坦、氯沙坦、替米沙坦和奥美沙坦转换为坎地沙坦对清晨高血压和心率的影响。
Blood Press. 2013 Sep;22 Suppl 1:29-37. doi: 10.3109/08037051.2013.757844. Epub 2013 Jan 18.
8
Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.血管紧张素II受体阻滞剂替米沙坦与缬沙坦联合氢氯噻嗪的疗效比较:一项大型验证性试验。
Blood Press Monit. 2008 Feb;13(1):21-7. doi: 10.1097/MBP.0b013e3282f3859d.
9
Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study.血管紧张素II 1型受体阻滞剂对2型糖尿病高血压患者血清尿酸的比较影响:一项回顾性观察研究。
Cardiovasc Diabetol. 2013 Nov 4;12:159. doi: 10.1186/1475-2840-12-159.
10
Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home.小剂量吲达帕胺联合降压治疗的疗效:通过家庭血压自我监测进行评估
Clin Exp Hypertens. 2005 May;27(4):331-41.

引用本文的文献

1
Evening versus morning dosing regimen drug therapy for hypertension.高血压的晚间与晨间给药方案药物治疗。
Cochrane Database Syst Rev. 2024 Feb 14;2(2):CD004184. doi: 10.1002/14651858.CD004184.pub3.
2
Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial.DASH 饮食和氯沙坦对高血压患者血尿酸的影响:一项随机试验的结果。
J Clin Hypertens (Greenwich). 2023 Oct;25(10):915-922. doi: 10.1111/jch.14721. Epub 2023 Sep 11.
3
A personal history of research on hypertension From an encounter with hypertension to the development of hypertension practice based on out-of-clinic blood pressure measurements.
高血压研究的个人史 从偶然遇到高血压到基于诊室外血压测量的高血压实践发展。
Hypertens Res. 2022 Nov;45(11):1726-1742. doi: 10.1038/s41440-022-01011-1. Epub 2022 Sep 8.
4
Antihypertensive effect of azilsartan versus olmesartan in patients with essential hypertension: a meta-analysis.阿齐沙坦与奥美沙坦对原发性高血压患者的降压效果:一项荟萃分析。
Ir J Med Sci. 2019 May;188(2):481-488. doi: 10.1007/s11845-018-1859-1. Epub 2018 Jul 3.
5
Renin-angiotensin system in the kidney: What is new?肾脏中的肾素-血管紧张素系统:有哪些新进展?
World J Nephrol. 2014 Aug 6;3(3):64-76. doi: 10.5527/wjn.v3.i3.64.
6
What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?对于合并糖尿病和非糖尿病肾损害的高血压患者,哪种血管紧张素 II 受体阻滞剂为基础的联合治疗方案更有利于血压控制?
Cardiovasc Diabetol. 2012 Apr 10;11:32. doi: 10.1186/1475-2840-11-32.
7
Beneficial cardiometabolic actions of telmisartan plus amlodipine therapy in elderly patients with poorly controlled hypertension.替米沙坦联合氨氯地平治疗血压控制不佳的老年患者的有益心脏代谢作用。
Clin Cardiol. 2011 Apr;34(4):261-5. doi: 10.1002/clc.20855. Epub 2011 Feb 1.
8
New standards in hypertension and cardiovascular risk management: focus on telmisartan.高血压与心血管风险管理的新标准:聚焦替米沙坦
Vasc Health Risk Manag. 2010 Mar 24;6:113-33. doi: 10.2147/vhrm.s7857.
9
Direct renin inhibitors: a new approach to antihypertensive drug treatment.直接肾素抑制剂:抗高血压药物治疗的新方法。
J Clin Hypertens (Greenwich). 2007 Aug;9(8):615-21. doi: 10.1111/j.1524-6175.2007.07125.x.
10
A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours.替米沙坦治疗高血压的综述:清晨时段的血压控制
Vasc Health Risk Manag. 2006;2(3):195-201. doi: 10.2147/vhrm.2006.2.3.195.